Anzeige
Mehr »
Login
Freitag, 10.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
100 % Anstieg in zwei Tagen: Das technische Signal, das Wall Streets Bären in Panik versetzt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
150 Leser
Artikel bewerten:
(0)

RingConn LLC: RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air

Finanznachrichten News

LAS VEGAS, Jan. 10, 2025 /PRNewswire/ -- RingConn, a leading smart wearable brand, is proud to announce its participation in this year's CES, showcasing two groundbreaking products on the international stage: the RingConn Gen 2, which successfully raised over $4 million on Kickstarter in September, and the debut of the RingConn Gen 2 Air.

RingConn at CES 2025

Record-breaking Launch of RingConn Gen 2

Launched in August 2024, the RingConn Gen 2 crowdfunding project achieved remarkable success as the world's first smart ring to offer sleep apnea monitoring. With its industry-leading design, exceptional user experience, and the ultrathin hardware design, the Gen 2 garnered over $4 million in sales from more than 18,000 backers globally, setting a record for wearable brands on the platform. By the end of 2024, RingConn reached a significant milestone with over 150,000 users across 80 countries. The international debut of the Gen 2 at CES received widespread acclaim from both media and consumers.

A senior editor remarked that RingConn Gen 2 emerges as a standout smart ring at CES, offering groundbreaking sleep apnea monitoring, ultra-thin design, and comprehensive health tracking without subscription fees. Its 90.7% sleep apnea detection accuracy and 12-day battery life make it a promising innovation in wearable health technology.

Introducing AI Health Partner

Building on the success of Gen 2, the team has continuously innovated and introduced the AI Health Partner feature. This service aims to address the limitations of current AI and large language models (LLM) in health scenarios by integrating with smart wearable devices, to provide personalized, proactive, and data-driven partnering for everyday behaviors. Now, the AI Health Partner provides smart health summaries, AI-powered health goals, and intelligent health suggestions. In the long run, it should help user in providing deep Insights, Real-Time feedback, and sustainable health management, by establishing a central system that integrates user data to provide personalized health insights, AI Health Partner will conduct deeper analyses and offer recommendations.

RingConn Gen 2 Air: The Future of Smart Wearable

At CES this year, RingConn also introduced the latest addition to its product line: the RingConn Gen 2 Air. Upholding the vision of "AI Health For All - All People, All Time, All Scenarios," this product aims to deliver cutting-edge health monitoring technology experiences to everyone. The Gen 2 Air embodies an innovative approach to smart ring design, simultaneously delivering a comprehensive health monitoring experience that builds upon the foundational capabilities of its predecessor. It offers a fresh fashion choice for the health-conscious consumers with seven different colors of ring protectors that can match unique daily outfits, sparking various style expressions. Additionally, users can enjoy nine color options for blind box finger sleeves, enhancing their smart fashion experience.

About RingConn:

Established in 2021, RingConn is a leading personal health technology company dedicated to creating innovative products and services that transform the experience of maintaining personal wellness. Guided by the principle of "Hardware + Software + Services," RingConn aims to provide unique products and services for people's health.

Contact:
Claudia Liu
PR Supervisor
Claudia.L@ringconn.com

Photo - https://mma.prnewswire.com/media/2595273/WechatIMG49.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/ringconn-takes-center-stage-at-ces-2025-with-innovative-wearables-gen-2-and-gen-2-air-302347859.html

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.